Skip to content
Checked.be
Complete company report
Generated 25-08-2026
Active BE 0629.859.206Public limited company

B.C. Oncology

Da Vincilaan 1 ·1930 Zaventem, Belgium· 11 yrs active
Conclusion Checked

The computed 12-month bankruptcy probability of B.C. Oncology is 1.0% (low). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 11 yrs
Board 3
Locations 1
Publications 12
Bankruptcy probability (12 mo) Checked model v1 · free
1.0% Low
0%0,5%1,5%4%10%≥25%
No NACE activity registered +Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Established
Founded in 2015, 11 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (verkort). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2025 verkort 22-05-2026 2026-00119694
31-12-2024 verkort 03-07-2025 2025-00230425
31-12-2023 verkort 06-06-2024 2024-00115490
31-12-2022 verkort 09-06-2023 2023-00126073
31-12-2021 verkort 18-07-2022 2022-20210556
31-12-2020 verkort 26-07-2021 2021-39800059
31-12-2019 verkort 23-06-2020 2020-20300213
31-12-2018 verkort 14-06-2019 2019-19400583
31-12-2017 verkort 31-08-2018 2018-59400305
31-12-2016 verkort 30-08-2017 2017-54300084
Directors & mandates 6 directors
Current directors & mandates
  • MARA CONSULTINGLegal entity
    Director· perm. rep.: Matthias DE WITTE
    State Gazette act 22028302 (02-03-2022)
    Current
    02-02-2022 → present
  • axis adviceLegal entity
    Director· perm. rep.: Lionel DE HEMPTINNE
    State Gazette act 21127887 (27-10-2021)
    Current
    27-10-2021 → present
    3 events
    • 27-10-2021 Resigned· Director
    • 27-10-2021 Mandate renewed· Director
    • 19-11-2019 Appointed· Director
  • WEPAVENLegal entity
    Director· perm. rep.: Janwillem NAESENS
    State Gazette act 21127887 (27-10-2021)
    Current
    27-10-2021 → present
    4 events
    • 27-10-2021 Resigned· Director
    • 27-10-2021 Mandate renewed· Director
    • 27-10-2021 Resigned· Managing director
    • 27-10-2021 Mandate renewed· Managing director
Historic, not recently confirmed (2)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • WEPAVEN B.V.B.A.
    Director
    State Gazette act 20031125 (26-02-2020)
    Not recently confirmed
    last confirmed in an act from 2020
    2 events
    • 26-02-2020 Appointed· Director
    • 26-02-2020 Appointed· Managing director
  • On.K.O. B.V.B.A.Legal entity
    Managing director· perm. rep.: Janwillem NAESENS
    State Gazette act 19150322 (19-11-2019)
    Not recently confirmed
    last confirmed in an act from 2019
    3 events
    • 26-02-2020 Resigned· Director
    • 16-12-2019 Resigned· Managing director
    • 19-11-2019 Appointed· Managing director
Former directors (1)
  • XiaLegal entity
    Director· perm. rep.: Bart VAN HOOLAND
    State Gazette act 19150322 (19-11-2019)
    Former
    - → 03-05-2019
    2 events
    • 03-05-2019 Resigned· Director
    • 03-05-2019 Resigned· Managing director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Legal Structure
NACE primary -
Legal form Public limited company(014)
Incorporation07-05-2015
StatusActive
Postal code1930
Connections & network 40 connected companies
Group structure
axis advice
Sits on the board · 6 subsidiaries · 1 location
Control→
MARA CONSULTING
Sits on the board · 6 subsidiaries · 1 location
Control→
WEPAVEN
Sits on the board · 4 subsidiaries
Control→
Network connections
Aura Invest
Shared corporate director
→
DCOV I
Shared corporate director
→
DELKA
Shared corporate director
→
DINVEI
Shared corporate director
→
Show 2 more network connections
DROIA Facility Services
Shared corporate director
→
Metaptys
Shared corporate director
→
31 further connected companies in this network. Available in Kantoor S. See plans →
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Ownership & control 3 parties
Control over this companysits on this company's board3
axis advice
6 subsidiaries · 1 location
MARA CONSULTING
6 subsidiaries · 1 location
WEPAVEN
4 subsidiaries
controls
B.C. OncologyBE 0629.859.206

Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.

Establishment units 1 location
B.C. Oncology
Da Vincilaan 1, 1930 ZaventemSpeur- en ontwikkelingswerk op biotechnologisch gebied
since 20152.244.200.809
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23094D0111/00M002 Flanders 8,965 m² 1 · 1,730 m² 45.7 m · 14 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 22 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
22-05-2026
NBB filing Annual accounts filed
fiscal year 2025 · verkort
09-04-2026
State Gazette act Director changes
2025
03-07-2025
NBB filing Annual accounts filed
fiscal year 2024 · verkort
2024
06-06-2024
NBB filing Annual accounts filed
fiscal year 2023 · verkort
2023
09-06-2023
NBB filing Annual accounts filed
fiscal year 2022 · verkort
2022
20-07-2022
State Gazette act Registered-office change
v3.2
18-07-2022
NBB filing Annual accounts filed
fiscal year 2021 · verkort
02-03-2022
State Gazette act Director changes
v3.2
2021
27-10-2021
State Gazette act Director changes
v3.2
26-07-2021
NBB filing Annual accounts filed
fiscal year 2020 · verkort
2020
23-06-2020
NBB filing Annual accounts filed
fiscal year 2019 · verkort
26-02-2020
State Gazette act Director changes
v3.2
2019
19-11-2019
State Gazette act Director changes
v3.2
14-06-2019
NBB filing Annual accounts filed
fiscal year 2018 · verkort
12-06-2019
State Gazette act Capital & shares
v3.2
14-01-2019
State Gazette act Capital & shares
v3.2
2018
31-08-2018
NBB filing Annual accounts filed
fiscal year 2017 · verkort
28-06-2018
State Gazette act Capital & shares
v3.2
2017
30-08-2017
NBB filing Annual accounts filed
fiscal year 2016 · verkort
23-01-2017
State Gazette act Capital & shares
v3.2
2016
28-01-2016
State Gazette act Capital & shares
v3.2
2015
19-05-2015
State Gazette act Incorporation
oprichting
Belgian State Gazette reading coverage 0 of 12 acts read

We know of 12 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 12 acts
Capital history · 5
12-06-2019
v3.2
14-01-2019
v3.2
28-06-2018
v3.2
23-01-2017
v3.2
28-01-2016
v3.2
Address history · 1
20-07-2022
v3.2
All acts · 12 updated 4 months ago
2026
09-04-2026 2 directors appointed, 1 resigning Director changes
  • Alexander DEPAUW, Vaste vertegenwoordiger
  • Janwillem NAESENS, Gedelegeerd bestuurder
  • Matthias DE WITTE, Vaste vertegenwoordiger
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Matthias DE WITTE",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": "0717.880.370",
        "name": "MARA CONSULTING BV",
        "address": "1730 ASSE, Petrus Ascanusstraat 124/a",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De bijzondere algemene vergadering d.d. 01.02.2026 heeft het ontslag aanvaard van MARA CONSULTING BV, met zetel te 1730 ASSE, Petrus Ascanusstraat 124/a, ingeschreven in het rechtspersonenregister te BRUSSEL met als ondernemingsnummer 0717.880.370 en met als vaste vertegenwoordiger Matthias DE WITTE",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Alexander DEPAUW",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": "0764.416.616",
        "name": "ADP VENTURES BV",
        "address": "2018 ANTWERPEN, Balansstraat 26 bus 101",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De bijzondere algemene vergadering d.d. 01.02.2026 heeft beslist om ADP VENTURES BV, met zetel te 2018 ANTWERPEN, Balansstraat 26 bus 101, ingeschreven in het rechtspersonenregister te ANTWERPEN afdeling ANTWERPEN met als ondernemingsnummer 0764.416.616 en met als vaste vertegenwoordiger Alexander D",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2031"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Janwillem NAESENS",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "WEPAVEN BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "WEPAVEN BV. met als vaste vertegenwoordiger Janwillem NAESENS, gedelegeerd bestuurder.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2026-04-09",
    "filing_date": "2026-04-01",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "bijzondere_algemene_vergadering",
      "date": "2026-02-01",
      "unanimous": true
    },
    {
      "body": "bijzondere_algemene_vergadering",
      "date": "2026-02-01",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV",
    "_kbo_extracted_mismatch": "0629.859.209"
  },
  "publication_proxy": {
    "kind": null,
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
2022
20-07-2022 Registered office moved from Meise to Zaventem Registered-office change
  • Brusselsesteenweg 11, 1860 Meise → Da Vincilaan 1, 1930 Zaventem
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Zaventem",
        "region": "Vlaams Gewest",
        "street": "Da Vincilaan",
        "country": "BE",
        "postcode": "1930",
        "box_number": null,
        "street_number": "1"
      },
      "old_address": {
        "city": "Meise",
        "region": "Vlaams Gewest",
        "street": "Brusselsesteenweg",
        "country": "BE",
        "postcode": "1860",
        "box_number": null,
        "street_number": "11"
      },
      "effective_date": "2022-06-20",
      "evidence_quote": "de bestuurders besluiten eenparig om de zetel van de vennootschap te verplaatsen naar Da Vincilaan 1, 1930 Zaventem, Belgi\u00EB."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
02-03-2022 Matthias DE WITTE appointed as director Director changes
  • Matthias DE WITTE, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Matthias DE WITTE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0717880370",
        "name": "MARA CONSULTING BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2022-02-02",
      "evidence_quote": "De aandeelhouders hebben op 23.12.2021 beslist om MARA CONSULTING BV, met zetel te 1730 ASSE, Petrus Ascanusstraat 124/a, ingeschreven in het rechtspersonenregister te BRUSSEL met als ondernemingsnummer 0717.880.370 en met als vaste vertegenwoordiger Matthias DE WITTE, te benoemen als bestuurder met"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
2021
27-10-2021 3 resigning, 3 reappointed Director changes
  • Lionel DE HEMPTINNE, Bestuurder
  • Janwillem NAESENS, Bestuurder
  • Janwillem NAESENS, Gedelegeerd bestuurder
  • Lionel DE HEMPTINNE, Bestuurder
  • Janwillem NAESENS, Bestuurder
  • Janwillem NAESENS, Gedelegeerd bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lionel DE HEMPTINNE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0894930314",
        "name": "AXIS ADVICE SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering d.d. 30.06.2021 stelt vast dat het mandaat van volgende bestuurders vervalt: - AXIS ADVICE SRL, met zetel te 1301 BIERGES, Avenue des Tarins 8, ingeschreven in het rechtspersonenregister te NIJVEL, met als ondernemingsnummer 0894.930.314 en met als vaste vertegenwoordiger Lio"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Janwillem NAESENS",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0828052277",
        "name": "WEPAVEN BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering d.d. 30.06.2021 stelt vast dat het mandaat van volgende bestuurders vervalt: - WEPAVEN BV, met zetel te 1970 WEZEMBEEK-OPPEM, Wezembeekstraat 31, ingeschreven in het rechtspersonenregister te BRUSSEL met als ondernemingsnummer 0828.052.277 en met als vaste vertegenwoordiger J"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lionel DE HEMPTINNE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0894930314",
        "name": "AXIS ADVICE SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering d.d. 30.06.2021 heeft beslist om volgende bestuurders te herbenoemen: - AXIS ADVICE SRL, voormeld. De vennootschap AXIS ADVICE SRL heeft de natuurlijke persoon Lionel DE HEMPTINNE aangeduid als vaste vertegenwoordiger van de vennootschap."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Janwillem NAESENS",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0828052277",
        "name": "WEPAVEN BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering d.d. 30.06.2021 heeft beslist om volgende bestuurders te herbenoemen: - WEPAVEN BV, voormeld. De vennootschap WEPAVEN BV heeft de natuurlijke persoon Janwillem NAESENS aangeduid als vaste vertegenwoordiger van de vennootschap."
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Janwillem NAESENS",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0828052277",
        "name": "WEPAVEN BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De raad van bestuur d.d. 30.06.2021 stelt vast dat het mandaat van WEPAVEN BV, voormeld, als gedelegeerd bestuurder is vervallen"
    },
    {
      "kind": "director_renew",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Janwillem NAESENS",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0828052277",
        "name": "WEPAVEN BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "en herbenoemt WEPAVEN BV, voormeld, met als vaste vertegenwoordiger Janwillem NAESENS, als gedelegeerd bestuurder."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
2020
26-02-2020 2 directors appointed, 2 resigning Director changes
  • WEPAVEN B.V.B.A., Bestuurder
  • WEPAVEN B.V.B.A., Gedelegeerd bestuurder
  • On.K.O. B.V.B.A., Bestuurder
  • On.K.O. B.V.B.A., Gedelegeerd bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "On.K.O. B.V.B.A.",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "De bijzondere algemene vergadering d.d. 16.12.2019 heeft het ontslag aanvaard van On.K.O. B.V.B.A., met maatschappelijke zetel te 1970 WEZEMBEek-OPPEM, Wezembeekstraat 33, ingeschreven in het rechtspersonenregister te BRUSSEL met als ondernemingsnummer 0543.508.717 en met als vaste vertegenwoordiger"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "WEPAVEN B.V.B.A.",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-02-26",
      "evidence_quote": "De bijzondere algemene vergadering d.d. 16.12.2019 heeft beslist om WEPAVEN B.V.B.A., met maatschappelijke zetel te 1970 WEZEMBEEK-OPPEM, Wezembeekstraat 31, ingeschreven in het rechtspersonenregister te BRUSSEL met als ondernemingsnummer 0828.052.277 en met als vaste vertegenwoordiger Jarwiflem NAE"
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "On.K.O. B.V.B.A.",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-12-16",
      "evidence_quote": "De raad van bestuur d.d. 16.12.2019 heeft het ontslag vastgesteld van On.K.O. B.V.B.A., met maatschappelijke zetel te 1970 WEZEMBEEK-OPPEM, Wezembeekstraat 33, ingeschreven in het rechtspersonenregister te BRUSSEL met als ondernemingsnummer 0543.508.717 en met als vaste vertegenwoordiger Janwillem N"
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "WEPAVEN B.V.B.A.",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-02-26",
      "evidence_quote": "De raad van bestuur d.d. 16.12.2019 heeft beslist om WEPAVEN B.V.B.A., met maatschappelijke zetel te 1970 WEZEMBEEK-OPPEM, Wezembeekstraat 31, ingeschreven in het rechtspersonenregister te BRUSSEL met als ondernemingsnummer 0828.052.277 en met als vaste vertegenwoordiger Janwillem NAESENS, te benoem"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
2019
19-11-2019 2 directors appointed, 2 resigning Director changes
  • Lionel DE HEMPTINNE, Bestuurder
  • Janwillem NAESENS, Gedelegeerd bestuurder
  • Bart VAN HOOLAND, Bestuurder
  • Bart VAN HOOLAND, Gedelegeerd bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Bart VAN HOOLAND",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0543641745",
        "name": "XIA B.V.B.A.",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2019-05-03",
      "evidence_quote": "De algemene vergadering d.d. 15.05.2019 heeft het ontslag vastgesteld en aanvaard van XIA B.V.B.A., met maatschappelijke zetel te 9831 SINT-MARTENS-LATEM, Pontstraat 90, ingeschreven in het rechtspersonenregister te GENT afdeling GENT met als ondernemingsnummer 0543.641.745 en met als vaste vertegen"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lionel DE HEMPTINNE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0894930314",
        "name": "AXIS ADVICE S.P.R.L.",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering d.d. 15.05.2019 heeft beslist om AXIS ADVICE S.P.R.L., met maatschappelijke zetel te 1301 BIERGES, Avenue des Tarins 8, ingeschreven in het rechtspersonenregister te NIJVEL met als ondernemingsnummer 0894.930.314 en met als vaste vertegenwoordiger Lionel DE HEMPTINNE te benoe"
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Bart VAN HOOLAND",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0543641745",
        "name": "XIA B.V.B.A.",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2019-05-03",
      "evidence_quote": "De raad van bestuur d.d. 15.05.2019 heeft het ontslag vastgesteld van XIA B.V.B.A., met maatschappelijke zetel te 9831 SINT-MARTENS-LATEM, Pontstraat 90, ingeschreven in het rechtspersonenregister te GENT afdeling GENT met als ondernemingsnummer 0543.641.745 en met als vaste vertegenwoordiger Bart V"
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Janwillem NAESENS",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "On.K.O. B.V.B.A.",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "On.K.O. B.V.B.A., met als vaste vertegenwoordiger Janwillem NAESENS. gedelegeerd bestuurder."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
12-06-2019 Capital decrease of €200,000 to €9,471,800 Capital & shares
  • €9.671.800 → €9.471.800
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 200000.0,
      "currency": "EUR",
      "after_eur": 9471800.0,
      "delta_eur": -200000.0,
      "before_eur": 9671800.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-05-24",
      "evidence_quote": "De vergadering beslist het maatschappelijk kapitaal ten belope van tweehonderdduizend euro (200.000,00 EUR) te verminderen om het te herleiden van negen miljoen zeshonderdeenenzeventigduizend achthonderd euro (9.671.800,00 EUR) tot negen miljoen vierhonderdeenenzeventigduizend achthonderd euro (9.471.800,00 EUR)",
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
14-01-2019 Capital increase of €180,000 to €9,671,800 Capital & shares
  • €9.491.800 → €9.671.800
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 180000.0,
      "currency": "EUR",
      "after_eur": 9671800.0,
      "delta_eur": 180000.0,
      "before_eur": 9491800.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2018-12-21",
      "evidence_quote": "De vergadering beslist het kapitaal te verhogen ten belope van honderdtachtigduizend euro (180.000,00 EUR) door inbreng in geld, om het te brengen van negen miljoen vierhonderdeenennegentigduizend achthonderd euro (9.491.800,00 EUR) naar negen miljoen zeshonderdeenenzeventigduizend achthonderd euro (9.671.800,00 EUR)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
2018
28-06-2018 Capital increase of €7,500,000 to €9,491,800 Capital & shares
  • €1.991.800 → €9.491.800
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 7500.0,
      "currency": "EUR",
      "after_eur": 9491800.0,
      "delta_eur": 7500000.0,
      "before_eur": 1991800.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2018-05-31",
      "evidence_quote": "De vergadering beslist het kapitaal te verhogen ten belope van 7.500,000 EUR door inbreng in geld, om het te brengen van een miljoen negenhonderdeenennegentigduizend achthonderd euro (1.991.800,00 EUR) naar 9.491.800 EUR",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
2017
23-01-2017 Capital increase of €720,000 to €1,991,800 Capital & shares
  • €1.271.800 → €1.991.800
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 720000.0,
      "currency": "EUR",
      "after_eur": 1991800.0,
      "delta_eur": 720000.0,
      "before_eur": 1271800.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2016-12-20",
      "evidence_quote": "De vergadering beslist het kapitaal te verhogen ten belope van zevenhonderdtwintigduizend euro (720.000,00 EUR) door inbreng in geld om het te brengen van een miljoen tweehonderdeenenzeventigduizend achthonderd euro (1.271.800,00 EUR) naar een miljoen negenhonderdeenennegentigduizend achthonderd euro (1.991.800,00 EUR)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
2016
28-01-2016 Capital increase of €1,210,000 to €1,271,800 Capital & shares
  • €61.800 → €1.271.800
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 1210000.0,
      "currency": "EUR",
      "after_eur": 1271800.0,
      "delta_eur": 1210000.0,
      "before_eur": 61800.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2015-12-22",
      "evidence_quote": "De vergadering beslist het kapitaal te verhogen ten belope van een miljoen tweehonderdentienduizend euro (1.210.000,00 EUR) door inbreng in geld om het te brengen van eenenzestigduizend achthonderd euro (61.800,00 EUR) naar een miljoen tweehonderdeenenzeventigduizend achthonderd euro (1.271.800,00 EUR)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. ONCOLOGY",
    "legal_form": "NV"
  }
}
2015
19-05-2015 Incorporation of a new NV Incorporation
Summary: oprichting
Technical details 
{
  "kind": "oprichting",
  "seat": "1860 Meise, Brusselsesteenweg 11",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": "0543.354.606",
        "name": "DROIA INVEST S.A."
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "naamloos",
      "partner_role": null,
      "holder_org_kbo": "0543.354.606",
      "holder_org_name": "DROIA INVEST S.A.",
      "contribution_type": "cash",
      "amount_paid_in_eur": 61700,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 617,
      "amount_subscribed_eur": 61700,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "0553.535.547",
        "name": "DROIA S.A."
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "naamloos",
      "partner_role": null,
      "holder_org_kbo": "0553.535.547",
      "holder_org_name": "DROIA S.A.",
      "contribution_type": "cash",
      "amount_paid_in_eur": 100,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 1,
      "amount_subscribed_eur": 100,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 61800,
  "subject_company": {
    "kbo": "0629.859.206",
    "name_full": "B.C. Oncology",
    "legal_form": "NV"
  },
  "initial_directors": [],
  "incorporation_date": "2015-05-07",
  "post_incorporation_mandates": []
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Names & trade names
Legal nameNL B.C. Oncology
Registered office
Da Vincilaan 1
1930 Zaventem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative